text_1: Functional consequences of genomic alterations due to Myelodysplastic syndrome (MDS) are poorly understood due to the lack of an animal model.
text_2: Here we report on the use of human-induced pluripotent stem cells (hiPSCs) for modelling gliomagenesis.